Clobetasol propionate ophthalmic suspension, 0.05% (APP13007) was approved by the Food and Drug Administration in 2024.

Apotex Inc. (referred to as "Apotex" or "the Company") today announced it has entered into an exclusive licensing agreement with Formosa Pharmaceuticals ("Formosa", 6838.TW), for exclusive rights ...

Fluticasone propionate is a synthetic glucocorticoid used in the treatment of chronic asthma. Accurate measurement of this compound in human plasma is essential for pharmacokinetic studies and ...

Study: Short-chain fatty acid metabolites propionate and butyrate are unique epigenetic regulatory elements linking diet, metabolism and gene expression. Image Credit: Love Employee/Shutterstock ...

Clobetasol propionate ophthalmic suspension 0.05% for postoperative inflammation and pain after ocular surgery is now commercially available in the U.S., according to a press release from Eyenovia ...

In an exciting development for the food industry, Creative Enzymes has introduced Fermented Calcium Propionate, a cutting-edge ingredient poised to revolutionize food preservation methods. This ...

A research team led by Professor Chaogu Zheng from the School of Biological Sciences at The University of Hong Kong (HKU) recently discovered that propionate, a short-chain fatty acid (SCFA ...

Eyenovia acquired the U.S. commercial rights to clobetasol propionate ophthalmic suspension 0.05% from Formosa Pharmaceuticals in August 2023.